Clinical Trial Update: Efficacy of Temocillin in Urinary Tract Infection Due to ESBL Producing and AmpC Hyperproducing Enterobacteriaceae [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update assesses the efficacy of temocillin for urinary tract infections caused by ESBL-producing and AmpC-hyperproducing Enterobacteria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infections

Drugs mentioned

• Temocillin (temocillin)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Urinary Tract Infections | Phase 4 | Status: UNKNOWN